The Valley Desk

NCT03937635 · Interventional trial

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Overall registry status Recruiting

Phase 3

Conditions Smoldering Plasma Cell Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov